维普中文期刊产品整合服务
15篇 您的检索式:作者名="Wichit"
    题名 作者 年代 出处 被引量
1Dose requirement and complications of diluted and undiluted propofol for deep sedation in endoscopic retrograde cholangiopancreatography显示文摘BACKGROUND:In general,the dose requirement and complications of propofol are lower when used in the diluted form than in the undiluted form.The aim of this study was to determine the dose requirement and complications of diluted and undiluted propofol for deep sedation in endoscopic retrograde cholangiopancreatography.METHODS:Eighty-six patients were randomly assigned to either group D (diluted propofol) or U (undiluted propofol).All patients were sedated with 0.02-0.03 mg/kg midazolam (total dose ≤2 mg for age <70 years and 1 mg for age ≥70) and 0.5-1 μg/kg fentanyl (total dose ≤75 μg for age <70 and ≤50 μg for age ≥70).Patients in group U (42) were sedated with standard undiluted propofol (10 mg/mL).Patients in group D (44) were sedated with diluted propofol (5 mg/mL).All patients in both groups were monitored for the depth of sedation using the Narcotrend system.The primary outcome variable was the total dose of propofol used during the procedure.The secondary outcome variables were complications during and immediately after the procedure,and recovery time.RESULTS:All endoscopies were completed successfully.Mean propofol doses per body weight and per body weight per hour in groups D and U were 3.0 mg/kg,6.2 mg/kg per hour and 4.7 mg/kg,8.0 mg/kg per hour,respectively.The mean dose of propofol,expressed as total dose,dose/kg or dose/kg per hour and the recovery time were not significantly different between the two groups.Sedation-related adverse events during and immediately after the procedure were higher in group U (42.9%) than in group D (18.2%) (P=0.013).CONCLUSIONS:Propofol requirement and recovery time in the diluted and undiluted propofol groups were comparable.However,the sedation-related hypotension was significantly lower in the diluted group than the undiluted group.Somchai Amornyotin Wichit Srikureja Wiyada Chalayonnavin Siriporn Kongphlay 2011Hepatobiliary & Pancreatic Diseases International2011,10,3:15
2Economical effect of lumen apposing metal stents for treating benign foregut strictures显示文摘AIM To evaluate the clinical and economical efficacy of lumen apposing metal stent(LAMS) in the treatment of benign foregut strictures.METHODS A single center retrospective database of patients who underwent endoscopic treatment of benign foregut strictures between January 2014 and May 2017 was analyzed. A control group of non-stented patients who underwent three endoscopic dilations was compared to patients who underwent LAMS placement. Statistical tests performed included independent t-tests and fiveparameter regression analysis RESULTS Nine hundred and ninety-eight foregut endoscopic dilations were performed between January 2014 and May 2017. 15 patients underwent endoscopic LAMS placement for treatment of benign foregut stricture. Thirty-six patients with recurrent benign foregut strictures underwent three or more endoscopic dilations without stent placement. The cost ratio of endoscopic dilation to LAMS(stent, placement and retrieval) is 5.77. Cost effective analysis demonstrated LAMS to be economical after three endoscopic dilation overall.LAMS was cost effective after two dilations in the Postsurgical stricture subgroup. CONCLUSION Endoscopists should consider LAMS for the treatment of benign foregut strictures if symptoms persist past three endoscopic dilations. Post-surgical strictures may benefit from LAMS if symptoms persist after two dilations in a post-surgical. Early intervention with LAMS appears to be a clinically and economically viable option for durable symptomatic relief in patients with these strictures.Alexander Hallac Wichit Srikureja Eashen Liu Parag Dhumal Ashish Thatte Nishant Puri 2018World Journal of Gastrointestinal Endoscopy2018,10,10:3
3Safety of same-day endoscopic ultrasound and endoscopic retrograde cholangiopancreatography under conscious sedation显示文摘AIM: To assess the tolerability and safety of same-day tandem procedures, endoscopic ultrasound (EUS) followed by endoscopic retrograde cholangiopancreatography (ERCP) under conscious sedation. METHODS: A retrospective review was conducted at Loma Linda University Medical Center, a tertiary-care center. All 54 patients who underwent EUS followed by ERCP (group A) from 2004 to 2006 were included in the study. A second group of 56 patients who underwent EUS only (group B), and a third group of 53 patients who underwent ERCP only (group C) during the same time period were selected consecutively as control groups for comparison. RESULTS: Conscious sedation was used in 96% of patients in group A. Mean dosages of meperidine and midazolam used in group A were signifi cantly higher than in group B or C. Mean recovery time in group A was not statistically longer than in group B or C. Therewas no signifi cant difference in the incidence of sedation-related and procedural-related complications. CONCLUSION: Tandem EUS/ERCP procedure can be safely performed under conscious sedation with minimal adverse events. Combined procedures, however, are associated with higher dosages of sedatives, and slightly longer recovery time.Kendrick Che Natasha Muckova Snorri Olafsson Wichit Srikureja 2010World Journal of Gastroenterology2010,16,26:2
4Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status显示文摘Srikiatkhachorn A Wichit S Gibbons RV 2012PLoS One2012,7,51:1
5Biology of Zika virus in- fection in human skin cells显示文摘Hamel R Dejamac O Wichit S 2015J Virol2015,89,17:1
6Effect of coenzyme Q (10)as an antioxidant in beta-thalassemia/Hb E patients 显示文摘Kalpravidh R W Wichit A Siritanaratkul N 2005Biofac- tors2005,25,1234:1
7Biology of Zika Virus Infec- tion in Human Skin Cells显示文摘Hamel R Dejarnac O Wichit S 2015J Virol2015,89,17:1
8Grunberg SM (2009) Phase 2 trial results with the novel neurokinin-I receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy显示文摘Wichit Istvan A Vincent LH 2009Cancer2009,5,24:1
9Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemothera- py-induced nausea and vomiting in cancer padents receiving mod- erately emetogenic chemotherapy显示文摘Wichit A Istvan A Vincent LH 2009Cancer2009,115,24:1
10Endoscopic palliation of pancreatic adenocarcinoma显示文摘Wichit Srikureja Kenneth J Chang 2005Current Opinion in Gastroenterology2005,,5:1
11Influence of graft quality and marginal bone loss on implants placed in maxillary grafted sinus: a finite element study显示文摘Samroeng Inglam Siriwan Suebnukarn Wichit Tharanon Tratat Apatananon Kriskrai Sitthiseripratip 2010Medical & Biological Engineering & Computing2010,,7:1
12Overall survival benefit Observed with Lapatinib(L)plus Paclitaxel as first-line therapy in patients with HER2-overexpressing Metastatic Breast Cancer显示文摘Zhong-zhen Guan Binh-he xu Wichit Arpornwirat 2010CTRC-AACR San Antonio Breast Cancer Symposium P3-14-242010,3,:1
13Multi-sensor data fusion modelbased Kalman filter using fuzzy logic for human activity detec-tion显示文摘Wichit N Choksuriwong A International Journal of Information and Electronics0,,:1
14The Optimal Energy Management for Lighting of Bank in GMS (Greater Mekong Sub-region) Countries显示文摘Chaiyapat Kumpeerakupt Somkuan Rimsmutchai Pomrapeepat Bhasaputra Woraratana Pattaraprakorn Arthit Sode-Yome Natapongkom Pawanawichien Surasak Tirawannavit Kitti Tirawannavit PanuponSamerpark Wichit Krueasuk 2013Journal of Energy and Power Engineering2013,7,4:0
15The Optimal Design of Lighting Systems for Designated Office Building in Thailand显示文摘Surasak Panjavaranont Pomrapeepat Phasaputra Woraratana Pattaraprakom Arthit Sode-Yome Kitti Tirawannavit Chaiyapat Kumpeerakupt Somkhun Rimsmutchai Wichit Krueasuk Natapongkom Pawanawichien 2013Journal of Energy and Power Engineering2013,7,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费